These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5353474)

  • 1. Bioactivation of 5-oxo-(D-trans-2-phenylcyclopropyl)-L-2-pyrrolidone carboxamide (EX 4883) into a monoamine oxidase inhibitor by a soluble fraction enzyme system.
    McMonigle JJ; Horita A
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):53-61. PubMed ID: 5353474
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of biotransformation on the pharmacology of the monoamineoxidase inhibitor 5-oxo-N-(d-trans-2-phenylcyclopropyl)-1-2-pyrrolidone-carboxamide (EX-4883).
    Lowe MC; Horita A
    Eur J Pharmacol; 1973 Jan; 21(1):46-52. PubMed ID: 4709204
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of bioactivation on the pharmacology of the potent monoamine oxidase inhibitor 5-oxo-N-(D-trans-2-phenylcyclopropyl)-L-2-pyrrolidine-carboxamide (EX-4883).
    Lowe MC; Horita A
    Proc West Pharmacol Soc; 1969; 12():87. PubMed ID: 5812307
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibition of brain monoamine oxidase in the rat by multiple pyrazidol administration].
    Verevkina IV; Asnina VV; Gorkin VZ; Mashkovskiĭ MD
    Biull Eksp Biol Med; 1985 May; 99(5):583-4. PubMed ID: 4005414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of monoamine oxidase inhibitors and reserpine on the gamma-aminobutyric acid content of the rat brain].
    Popov N; Matthies HJ
    Acta Biol Med Ger; 1967; 18(1):91-8. PubMed ID: 5587220
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of D,L-malic acid dibenzylhydrazide on changes in the antioxidizing activity of lipids and monoamine oxidase activity in mouse organs].
    Kairane ChB; Baumanis EA; Burlakova EB; Gorkin VZ; Kalninia IE
    Vopr Med Khim; 1979; 25(6):776-81. PubMed ID: 516540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibitors of monoamine oxidase (MAO). 5. 1-Substituted phenoxathiin inhibitors containing no nitrogen that inhibit MAO A by binding it to a hydrophobic site.
    Harfenist M; McGee DP; Reeves MD; White HL
    J Med Chem; 1998 Jun; 41(12):2118-25. PubMed ID: 9622553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on monoamine oxidase. 5. Enzymic differences in the monoamine oxidases in the brain and liver].
    Tatsuo F
    Nihon Yakurigaku Zasshi; 1968 Jul; 64(4):393-8. PubMed ID: 4387722
    [No Abstract]   [Full Text] [Related]  

  • 9. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
    Maki Y
    Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase inhibition by Rhodiola rosea L. roots.
    van Diermen D; Marston A; Bravo J; Reist M; Carrupt PA; Hostettmann K
    J Ethnopharmacol; 2009 Mar; 122(2):397-401. PubMed ID: 19168123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Data on the biochemical mechanism of action of antidepressive psychopharmacologic agents].
    Baconcini C; Muzio M
    Sist Nerv; 1971; 23(7):25-35. PubMed ID: 4360412
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
    Khalil AA; Davies B; Castagnoli N
    Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiotracer of the distribution of a new psychotropic agent in mice: L-2-pyrrolidone-5-carboxylate of dimethylaminoethanol. I. Comparison with L-glutamic and L-2 pyrrolidone-5-carboxylic acids].
    Chanal JL; Marignan R; Cousse H; Baldet M
    Therapie; 1972; 27(1):35-46. PubMed ID: 5017555
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modern achievements in the field of catecholamine biochemistry].
    Gorkin VZ
    Vopr Med Khim; 1974 May; 20(3):227-38. PubMed ID: 4152064
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Mechanism of antidepressant efficacy of monoamine oxidase inhibitors: inhibition of monoamine oxidase or of catecholamine reuptake.
    Snyder SH
    Psychopharmacol Bull; 1974 Oct; 10(4):16. PubMed ID: 4431859
    [No Abstract]   [Full Text] [Related]  

  • 18. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase activity in the testis and epididymis of the rat.
    Penttilä A; Kormano M
    Ann Med Exp Biol Fenn; 1968; 46(4):557-63. PubMed ID: 5731568
    [No Abstract]   [Full Text] [Related]  

  • 20. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS.
    Fuxe K; Hökfelt T
    Triangle; 1971; 10(3):73-84. PubMed ID: 5138525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.